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Previous studies have shown that the process of epidermal 
differentiation is profoundly influenced by the level of intra-
cellular calcium within keratinocytes. In this study we have 
identified a 249-bp region, located 7.9 kb downstream from 
the promoter of the human keratin 1 (HK 1) gene, that is able 
to activate a SV 40 minimal promoter chloramphenicol acetyl 
transferase (CAT) construct in transfected murine keratino-
cytes. This activity was potentiated by increased levels of 
calcium and was independent of the position and orientation 
of the 249-bp fragment. The 249-bp fragment demonstrated 
a marked specificity for epidermal keratinocytes and was not 
active in fibroblasts or in a breast epithelial cell line. More-
over, this fragment could activate CAT expression in a con-
T he mammalian epidermis undergoes continuous re-newal and is comprised of four histologically distinct cellular layers, each representing a different matura-tion state. During this ordered, step-wise differentia-tion process the major cell type, the keratinocyte, mi-
grates from the proliferative basal layer through the spinous and 
granular layers to the fully differentiated squames of the stratum 
corneum. Keratinocytes in the proliferative compartment or basal 
cell layer express keratin (K) 5 and its obligate partner K14 as their 
major products [1 ,2]. Once a keratinocyte makes the commitment 
to differentiate, these genes are downregulated, although their pro-
tein products persist, and the genes for keratins Kl and KIO are 
induced [3 - 5]. The expression of K 1 precedes that of Kl 0 and has 
been shown to occur postmitotically [6]. Upon entering the granu-
lar layer, these genes are downregulated and other genes, notably 
filaggrin and loricrin, are induced [7 -9]. Although it is known that 
certain regulatory factors or modulators, such as calcium, retinoic 
acid, and vitamin D3, can affect epidermal differentiation both in 
vivo and in vitro, the precise mechanism of the differentiation process 
and its regulation has yet to be elucidated [10,11] . 
Various physico-chemical analyses on both murine and human 
skin have determined that a calcium gradient exists in the epidermis 
ill vivo [12,13]. Both extracellular and intracellular calcium are low 
in the basal and spinous layers, relative to serum and dermal levels, 
and the calcium concenrration rises progressively in the granular 
layer. The highest calcium levels are to be found in the granular cell 
that is just making the transition to a terminally differentiated 
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struct driven by the HKl promoter, which alone had no 
intrinsic CAT activity. A 102-bp fragment derived from the 
249-bp fragment was still responsive to calcium but no 
longer retained cell-type specificity. An AP-l site at position 
+ 7903 and encoded by both the 249-bp and 102-bp frag-
ments is implicated as the cis-element that mediates the cal-
cium response. Taken collectively, these data identify and 
characterize a regulatory element that is able to activate both 
heterologous or homologous promoters in response to in-
creased levels of intracellular calcium in keratinocytes. Key 
words: differentia tion/ transcri ption / expression /kera tino-
cyte.] Invest DermatoI101:506-513} 1993 
squame of the stratum corneum [13]. It is unclear how this gradient 
is generated or maintained in vivo but it can be mimicked itl vitro. 
Incremental increases in the calcium concentration of the culture 
medium result in a parallel increase in intracellular calcium [14 -16] 
and a concomitant progression of keratinocyte differentiation 
[14,17,18]. Thus, when primary keratinocytes (murine or human) 
are cultured in low-calcium media « 0.1 mM), the keratinocytes 
show a basal cell phenotype, proliferate rapidly, do not cornify, and 
express K5 and K14. When the calcium concentration is increased 
(> 0.1 mM), the cells stop dividing and begin to differentiate. As 
they do so, they downregulate K5 and K14 and induce the expres-
sion of Kl and KI0 [18,19]. Northern analysis indicates that the 
induction of differentiation-specific markers by calcium occurs at 
the level of transcription and that a cycloheximide-sensitive induci-
ble factor(s) is involved [18]. It is not known how much of the 
increase in intracellular calcium observed during differentiation is 
attributable to a mobilization of intracellular stores of calcium and 
how much is due to an influx of calcium from the extracellular 
environment. Certainly, some release of internal stores of calcium is 
mediated via inositol phosphate and its action on the endoplasmic 
reticulum [20]. It has also been suggested that intracellular calcium 
may, Ilia phosphatidic acid, after calcium ion channels in the mem-
brane and bring about a direct influx of extracellular calcium across 
the membrane [21] . Recent evidence would suggest that both reti-
noic acid and vitamin D3 mediate some of their responses through 
the modulation of intracellular calcium [16,21]. Thus calcium ap-
pears to be a fundamental regulatory modulator of epidermal differ-
entiation. 
We wished to investigate the roles of calcium in the regulation of 
keratinocyte differentiation at the molecular level and have at-
tempted to define the calcium-responsive elements within the 
human keratin (HK)I gene. Previous studies from this laboratory 
have shown that a 10.8-kb Eco RI fragment that encodes the HKl 
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gene conta ins all the info rmatio n necessary for expression o f HKl 
in the supra-basal layers of the epidermis of transgenic mice [22 -
24] . Fu rthermo re, w hen keratinocytes harvested from ~hese mice 
wer e placed in cult.ure, the express IOn of HKl could be.lIlduce? .by 
t h e a dditio n o f calcIUm to the culture m edium [24] . The ll1duclbillty 
of the HKl transgene by increased levels of calcium suggests that 
the c is-acting regulatory elem ents that mediate this specific re-
sponse m ust be located w ithin the 10.8-kb genomic fragm ent. A 
preliminary search for these putative cis-acting elements fo und that 
only a 4.4-kb fragment encoding the 3' fl anking regio n o f HKl 
stiITlUlated chloram phenicol acetyl transferase (CAT) ac tivity from 
a reporter plasmid in respo nse to elevated levels of calcium in the 
medium [2 5] . This fragment was active in both murine and human 
ep ide rmal keratinocytes, but inactive in NIH 3T 3 cells and primary 
mouse dermal fib roblasts [25J. W e have used deletio n analysis to 
furthe r defin e the sequences that m ediate the calcium response. In 
this s tudy w e report the identifica tion of a 249-bp fragment that is 
locat ed 7 .9 kb downstream from th e sta rt ofHKl gene transcription 
and e ncodes an ep idermal specific, calcium-inducible regulatory 
element. 
MATERIALS AND METHO DS 
P la sntids, Constructs, PCR Cloning All transfec tions employed 
pSV 2CAT [26] as the ~ositi ve control. Fragments to be t~sted for enhancer 
activity were cloned lIltO pAI0CAT2 [27] or pHK1(5 )CAT (Fig SA ). 
pHK 1 (5')CAT was derived from the 5' flanking sequences of HKl and the 
CAT coding sequence from pAI0CAT2 • The AT G codon of HKl was 
mutated to ATC to form a CIa I site and the resultant 1.2-kb Eco Rl /Cla I 
fragment , conta ining sequences from -1246 to + 60, was cloned in to 
pGEM7Z (Promega, Madison, WI) . T he 1.6-kb Hind III /Bam HI fragment 
from pAl OCAT 2 ' containing the CAT coding and SV 40 3' non-codlllg 
sequences, was subsequently ligated adjacent to the HK 1 promoter se-
quences. T h e 4.4-kb Bam HI /Eco RI fragment from the 3' flanking region of 
HKl , containing sequences from + 5107 to +9495 (Fig I) , was subcloned 
from the lO.8-kb Eco RI fragment [28] into the plasmid vector pSP72 
(Promega). The 2.7-kb Bam HI / BgI2 and 1.I -kb BgI 2 fragments, contain-
ing sequences between + 5107 and + 7819, and + 7820 and + 8866, respec-
tive ly, were cloned in to the Bgl 2 and Bam HI sites of pAI0CAT 2 in both 
orientations relatlve to CAT. The 0.6-kb Bgl 2/Eco RI fragment (+ 8867 to 
+9495) was subcloned as a Bgl 2 fragment by using the Bgl 2 site from the 
pSP7 2 polylinker into the Bgl 2 site of pAI0CAT2 • The constructs p2.7, 
pl . l, and pO.6 refer ~o the above fragments subcloned into pAI0CAT 2 at the 
Bgl 2 site, in an antisense onentatlon relatlve to the CAT codlllg sequence 
(Table I) . 
The sub-fragments of the 1.1-kb fragment were generated by polymerase 
chain reaction (PCR) [29] using oligonucleotid\!s whose position and orien-
ration are indicated in Fig 3A. Each pair of oligonucleotide primers encoded 
a Bgl 2 and a Bam HI site to fac ilitate the generation of head to tail concato-
mers of the sub-fragments. All PCR generated fragments were first cloned 
into t he Bam HI / Bgl 2 sites of pSP72 and their sequence verified. They were 
subsequently cloned into the Bgl 20r Bam HI sites of pAI0CAT2 0r the Bam 
HI si te of pHK(5')CAT, either as a single copy or as multimers and in both 
orientations relative to CAT (see T able I) . The 797-bp fragment was gener-
ated us ing oli gonucleot!de 6 and an oligonucleotide 3' to the Bgl 2 site at 
position + 8666 (see Fig 3). The 426-bp fragment was gen~ra ted USlllg 
oligonucleotides 1 and 7. The 249-bp fragment was generate? USll~g ohgonu-
cleo tides l and 5. The 5' 168-bp fragment was generated With ohgonucleo-
tides 1 and 4, whereas the 3' 168-bp fragment was generated with oligonu-
cleotides 2 and 5. The 102-bp fragment was generated with oligonucleotides 
land 3. 
Cell Culture, Transfection, CAT Assays Primary murine keratino-
cytes were prepared as described previously [30] and cultured in Eagles' 
minim al essentlal med IU m supplemented With 8% chclexed feta l calf serum 
and a calcium concentration of 0.05 mM (low-calcium medium). T o maxi-
mize transfection efficiency. primary keratinocytes were routinely main-
tained in low-calcium medium previously conditioned by primary dermal 
fibroblasts at 50% v/v [31] . The mammary epithelial cell line TM6 [32], 
NIH 3T 3 fibroblasts [33], and primary dermal fibroblasts wcre cultured in 
Dulbecco's modification of Eagle's minimal essential medium supplemented 
wi th 8% fetal calf serum or 8% donor calf serum fo r NIH 3T 3 cells. Primary 
dermal fi broblasts (1 X 106 cells). NIH 3T 3 (5 X 10' ), orTM6 breast cells (I 
X 106 ) were cultured 24 h prior to transfection, plated in 60-m111 dishes, and 
the fo llowing day incubated for 4 h with medium containing the calcium 
phosphate DNA coprecipitate [34]. Cells were then subjected to a 25% 
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Figure .1. A) Schematic representation of the l O.8-kb Eco RI fragment 
contam111g the HK I gene. The intron-exon structure is shown with the start 
of transcription (+ I) . The Bam HI, Bg12, and Eco RI sites used to generate 
the fragments tested for enhancer activity arc shown with their distance 
from the start of transcription in base pairs. T he sub-fragments are denoted 
by their size 111 kb. B) Identification of enhancer activity within the 3' 
flankmg reglOn ~f the HKI gene. The 2.7-, 1.1- , and 0.6-kb fragments 
depicted schematlca lly in A were cloned into pA10CAT2 (see Table I) and 
assayed after transfection into primary murine keratinocytes. A representa-
tive example of the assay is shown. pSV2 , pSV2CAT; pA. pAI 0CAT2 ; Cm, 
non-acetylated chloramphenicol; 1-Ac and 3-Ac, acetylated derivatives of 
chloramphemcol; L, 0.05 mM calcium; H , 0.35 mM calcium. 
dimethylsul fox ide (DMSO) shock for 3 min, washed, and re-fed until har-
ves t. Primary keratinocytes were transfected as before [31] . Briefly,S X 10· 
24-h-old keratlllocytes were cultured for 4 h in medium containing 0. 1 mM 
pot~sslUm/~.05 n.~ calcIUm (low-potass ium medium), which blocks the 
calcIUm dlfferentlatlon response [35]. All cells were incubated with the 
DNA co-precipitate fo r 4 h, followed by a DMSO shock (25% v/v, 3 min) , 
and returned to th.e appropnate culture medium. Twenty-four hours post 
t~ansfectlon , keratlllocytes were SWitched fro m low-potassium to low-cal-
ClUm Il:edlUm and the fo llowmg day switched to appropriate caIciuim con-
ccntratlOn (0.12, 0.15, 0.35, or 0.6 mM). Cells were transfected with 5 - 25 
Jig of plasmid DNA per dish dependin g on ce ll type, employ ing sonicated 
salmon sperm DNA as a carner fo r co-precipita tion where necessary. Cells 
we~e ha.rvested 4 d post transfectlon.and the CAT assay performed as de-
~cnbed .prevlOus ly [31], Without a sOlllcation step. CAT assays were normal-
Ized usmg an equal amount of protein. from each extract. T hin- layer cln o-
matography was performed uS1l1g stllcagcl chromatogram sheets (Kodak 
13181 sheets) in 95% chloroform and 5% ethanol (v/ v) and fo llowed by 
autoradlOgraphy. Chromatograms were later quantitated using a Betascope 
blot analyzer (Model #603, Betagen Corp., MA). Experiments were re-
peated at.least twice and 111 dupllcate, employing separate DNA preparations 
and media. 
RESULTS 
Previous w.ork had determined that an elem cnt(s) responsive to 
calcIUm ~eslded w lth1l1 a 4.4-bp fragm ent that consists of all the 3' 
non-codl11g and adjacent 3' fl ank ing informatio n of a H K l genomic 
clo ne [25J . In initial studies we frag mented th is regio n using conve-
niently available restrictio n sites (see M aterials and M ethods and Fig 
1) to generate fragments of 2. 7, 1.1 , and 0.6 kb, respectively. These 
were clo ned into the B gl 2 or Bam HI sites of the m inimal promoter 
C AT vector , pA10CAT2 . Fusio n CAT constructs were made that 
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Table 1. Constructs Generated by Inserting Various Genomic Sub-Fragments from the 3' Flanking Region 
of HK1 into Either pAIOCAT2 or pHKl(5') CAT 
Copy Cloning Fold 
Constructs Insert Number Vector Site' Oricntationt Induction:!: n§ 
pA10CAT2 None 
pSV2CAT SV40 Enhancer 1.0 7 
p2.7 +5107 to +7819 1 pAIOCAT2 5' AS 
p1.1 + 7820 to + 8866 1 pA10CAT2 5' AS 6.3 7 
pO.6 +8867 to +9495 1 pAIOCAT2 5' AS 2.4 4 
p249' + 7820 to + 8069 4 pAIOCAT2 5' S 7.6 2 
p249b + 7820 to + 8069 4 pAIOCAT2 5' AS NO~ NO 
p249' + 7820 to + 8069 4 pAIOCAT2 3' S 5.0 2 
p249J +7820 to +8069 4 pAlOCAT2 3' AS NO NO 
pl02' + 7820 to + 7922 3 pAI0CAT2 5' S 2.7 2 
pl02b + 7820 to + 7922 3 pAIOCAT2 5' AS 1.5 2 
None pHK1(5')CAT 
p249< +7820 to +8069 pHKl(5')CAT 3' AS 2.4 2 
p249! + 7820 to + 8069 1 pHKl(5')CAT 3' S 1.1 2 
p249g + 7820 to + 8069 4 pHKl(5')CAT 3' AS 5.7 4 
p249" + 7820 to + 8069 4 pHKl(5')CAT 3' S 5.9 2 
• 5':BgI2 site; 3': BamHI site. 
t Orientation relative to CAT coding sequence; AS, antisense; S, sense. 
t Ratio of CAT activity relative to pAl0CAT2 in high calcium over low calcium, data from at least rwo independent transfection experiments. 
§ Number of replicate experiments. 
, NO, Not determined. 
included both orientations of the test fragment relative to the CAT 
coding sequence. The 2.7-kb fragment failed to elicit a CAT re-
sponse in either position or orientation (Fig 1) and data are not 
shown. However, both the 1.1-kb and 0.6-kb fragments were able 
to activate pAIOCAT2 , with the 1.1-kb fragment consistently elic-
iting higher folds of CAT induction than the 0.6-kb fragment 
(Table I). This study reports on the further characterization of the 
more proximal (with respect to the HKl promoter) 1.1 -kb frag-
ment. 
The 1.1 -kb fragment was able to activat~ CAT only when placed 
5' to the CAT coding sequence and only in the antisense orientation 
relative to CAT (data not shown) . The ability of the 1.1-kb frag-
ment to respond to differing calcium levels is evident in Fig 2. In 
this experiment, an incremental increase in extracellular calcium 
Activity : 74 80 3 1 1 42 32 4 2 39 
Cm-
[ca2+JmM I() CD I() CD II) (\j II) II) CD (\j 0 0 0 0 0 (") ci 
0 0 0 ci 0 0 II II 
pSV2 pA10 p 1 . 1 
Figure 2. Identification of a calcium-responsive region within + 7820 and 
+ 8866 of the HK 1 gene. Primary murine keratinocytes were transfected in 
low-Ca>-+- medium (0.05 mM) and switched to the concentration of calcium 
indicated, as described in Materials alld Methods. CAT activity is expressed as 
the ratio of the activity of the test plasmid over the activity of pA 1 OCAT 2' A 
representative assay is shown. Cm, non-acetylated chloramphenicol; lAc 
and 3Ac, acetylated derivatives of chloramphenicol. 
resulted in a corresponding increase in CAT activity. Maximal CAT 
activity was observed at a calcium concentration of 0.15 mM. or 
higher in mouse primary keratinocytes. The SV40 enhancer plus 
promoter plasmid, pSV2CAT, on the other hand, displays almost no 
increase in activity in keratinocytes switched to a higher calcium 
environment (Fig 2, Table I). Note that the 1.1-kb fragment ex-
hibits some CAT activity in a low-calcium environment (0.05 mM. 
calcium), whereas the parent vector, pAIOCAT2 , shows no activity 
in keratinocytes, irrespective of the calcium concentration. 
The 1.1-kb fragment was further analyzed by producing three 
small sub-fragments of 797, 426, and 249 bp (Fig 3). These frag-
ments were placed either 5' or 3' of the CAT coding sequence and in 
both orientations. The 797-bp fragment was not able to elicit a 
response and has no intrinsic activity by itself but both the 426-bp 
and 249-bp fragments were able to stimulate CAT activity (data not 
shown and Fig 4). The 426-bp fragment was active only when 
placed 5' to CAT and in the 3' to 5' orientation, and as such behaved 
like the parent 1.1 -kb fragmen t (data not shown) . In contrast, how -
ever, the activity of the 249-bp fragment was independent of both 
position and orientation (Fig 4, and Table I). Furthermore, whereas 
a single copy of the 249-bp fragment exhibited relatively weak 
enhancing activity, multiple copies of this fragment showed activity 
similar to that of the 1.1-kb fragment (see Fig 6A). Thus the 249-bp 
fragment not only fulfills all the traditional criteria for an enhancer, 
but also retains the ability to respond to calcium. Having shown that 
the 249-bp fragment contains sequences that are able to activate a 
heterologous reporter, we then tested the abi lity of this fragment to 
activate the HK1 promoter. It had been reported previously that the 
proximal 5' region ofHKl did not contain enhancer sequences [25]. 
Based on this information, we replaced the SV 40 promoter of 
pAI0CAT2 with that of HK1. This CAT construct, denoted 
pHKl(5')CAT, contained 1.2 kb ofHKl 5' flanking sequences and 
had no intrinsic CAT activity on its own (Fig 5). The 249-bp frag-
ment, however, was able to activate this construct and, as was the 
case for the SV 40 minimal promoter, multimers of the 249-bp frag-
ment potentiated the levels of CAT activity of the HKl-driven 
construct. 
Because the 10.8-kb HKl genomic fragment is expressed exclu-
sively in the epidermis of trangenic mice [22-24]. we tested the 
cell-type specificity of the enhancer activity associated with the 
1.1-kb fragment and its derivatives. The 1.1-kb fragment and the 
249-bp fragment in both SV40 and HKl promoter CAT constructs 
were transfected into primary murine dermal fibrobl asts, NIH 3T3 
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A 
B 
... 7820 . . . . • • 
AGATCTGGGAAACTAAAGTACTGACAAGAGCTGGCTTGATCTGTGGATTTAGAAC;\ATGA 
~i 2 
3.., 
... 7880 agatct ggatcc 
GAGT'l'AGGTGGCCTTCAGGGAr:'~TI~~CTCTCCTTCACAGAAGAGCTGACCTCTGGG 
'.., 
... 7940 ggatcc 
GTCAACAGATATAGCACCTC'I"'l'TCCCAGGGACGCTACTGMTGAACAGTGATGTGTTCTT 
+8000 
ATACTCTGGCCCAGAT'M"TCTACATACTT'TC'M'AGGTTACM CT'T'T'ATTTAGTCACATTT 
"'APr'" 
5.., 
+8060 ggatcc 
CAGTACTGGGGATACTCCTG'ITTATC'M'CTTI'G<;ACTCGAGTT'T"M'ATGGGAAGGTCATG l 6 Xhol 
.81 20 
AAACAGAGAAAAATACM'M'TGCAGGGAAACTTACCAAGGCTTGTAAGGTTACAAGGATT 
... S180 
AAATGAAAACCCTCTGTAAGTCAGTATATAGTGAAGAAGTAAATTGAG'M'AGACCAAACG 
7., 
+82 40 ggatcc 
CCAAMTGCATCCGCATTAGAAAGACGATAAAGGAAGACTCTGGATTCAGTI'CTGTTCM 
Nsil 
+7820 Inducibil ity 
8g12 Xho 1 Nsl l 8 g12 
104 6 bp + 
42 6 + 
249 + 
7 9 7 
168 + 
16 8 
102 + 
Figure 3. A ) Nucleotide sequence of the HKl gene 3' flanking region 
between + 7820 and + 8299 (+ 1 corresponds to the start of transcription) . 
The sequence shown corresponds to the fi rs t 476 bp of Huff et al [25]. The 
cwo regions with homology to the AP-l consensus sequence [40] arc shown. 
T he positions of the restriction endonucleases Bgl 2, Xho I, and Nsi I are 
indicated. The Bam HI and Bgl 2 sites introduced by PCR are shown above 
the sequence. The numbers 1- 7 refer to the oligonucleotides used to gener-
ate the sub-fragments by polymerase chain reaction (PCR) as outlined in 
Materials and Methods. Bellt arrows, 5' and 3' terminii of the sub-fragments. 
Asterisks, nucleotides that mutate the proximal AP-l site upon introduction 
of a B gl 2 site. B) Schematic showing the parent l.l-kb Bgl 2 fragment and 
the sub-fragments generated from it. The size of the fragments is indicated in 
base pairs. + , the fragment has enhancer activity and can be induced by 
calcium; - , no enhancer activity. 
fib roblasts, and a breas t epithelial cell line TM6. The SV40 en-
hancer, plus promoter C AT construct pSV2CAT, w ere active in all 
cell s tested (Fig 6). H ow ever, constructs containing the 1.1-kb or 
249-bp fragm ents w ere active only in primary keratinocytes and 
displayed no activity in the other cells. Thus the calcium-inducible 
regulatory elements w ithin these fragments exhibit a high degree of 
cell-type specificity. 
In an attempt to narrow th e limits of the calcium-responsive 
regio n within the 249-bp fragment w e generated two overlapping 
168-bp fragments. These constructs are summarized in Fig 3. En-
hancer activity w as limited to the fi rst 168 bp of the 249-bp frag-
ment (da ta not shown) . An examination of the sequence within this 
region reveal ed a putative AP-l site at +7903 bp. This site is effec-
tively eliminated in the 3 ' 168-bp fragment by the insertion of a Bg i 
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Figure 4. Activity of the 249-bp fragment (+ 7820 to + 8069) on the SV40 
pr?moter of pAIOCAT2 • The p249 plasmid series were transfected into 
pnmary munne keratinocytes and assayed as outlined in Materials alld Meth-
ods. D~tall s of these constructs are summarized in Table I. A representative 
assay IS shown. pSV2 and pA denote pSV2CAT and pAIOCAT 2 , respec-
tively. L, 0.05 mm calcIUm; H , 0.35 mM calcium; Cm, non-acetylated 
chlorampherucol; 1 Ac and 3 Ac, acetylated derivatives of chloramphenicol. 
2 clo ningsite (Fig 3A ) and, as this fragm ent is inactive, we reasoned 
that a.ctlvlty of the calcium~responsive enhancer m ay be dependent 
on thiS AP~ 1 site: T o test tillS, we genera ted a 1 02-bp fragment that 
encodes thiS site IJltact (Fig 3) and it was indeed able to induce CAT 
activity in ~ransfected keratinocytes (Fig 7A ). Because the 249-bp 
fragmen t displayed absolute specificity for kera tinocytes, we tested 
A 
Cia 1 Hind 3 AATA ,U, 
..... ~~C::O~R.:.1-____ TJ·J~·-fC-;:Hjj;K;lll(--;cr.-A~TT-----i' H.~~ .~~ . 
-1246 t: +60 //+'6~5 
/~' 
B 
pHKI(S') p24g e P249 f p249 9 p249 h 
r-----,I rl ---- r----.,I i 1 ~I---'" 
3Ac-
lAc-
C 
Figun 5. A) Sehe,matic representation of HK1(5' )CAT . T his construct 
contal~s 1.2 kh of 5 flank111g 111formatlon fro m the HK1 gene including 60 
bp of 5. non-cod111g sequences up to the A TG codon, which was mutated to a 
Cia I site. The Eco RI/Cla I fragment was ligated to a Hind III/Bam HI 
pAI0C~T2 fragment containing the enti re CAT coding region as well as 
SV 40 3 non-cod111g sequences. Fragments to be tested for enhancer activity 
were cloned into the unique Bam HI site. B) Activity of the 249-bp fragment 
(+7820 to +8069) on the HKl promoter in primary murine keratinocytes. 
The onentatlon and copy number of the constructs are listed in Table I. A 
representative assay is shown. pHKl(S') refers to pHKl(5')CAT; L, 0.05 
mM calcIUm; H, 0.35 mM calcium; Cm, non-acetylated chloramphenicol; 1 
Ac and 3 Ac, acetylated derivatives of chloramphenicol. 
510 ROTHNAGEL ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
A 
pSV2 pA p249d 
1111 
p 1 . 1 
B 
pSV2 pA p249 d p249 9 p 1.1 
11"11 Ii II 
Ca2+ L H H L H L H L H H H L H L H L H 
c 
P 1 . 1 
D p1.1 
I r--1 rl ----'1 rl ---"1 '-1 -----, ,--------,1 rl---" 
Ca2+ L H H L H L H L H Ca2+ L H H L H L H L H 
Figure 6. Cell-type specific activity of the HKl enhancer within the 1.1-kb fragment (+ 7820 to + 8866) and the 249-bp fragment (+ 7820 to + 8069). 
Detai ls of the constructs are given in Table I. Constructs were transfected in A) primary murine keratinocytes, B) primary murine dermal fibroblasts, C) NIH 
3T3 fibroblasts, and D) TM6 breast epithelial cells, as described in Materials alld Methods. Representative CAT assay from two independent experiments. pSV2 , 
pSV2CAT; pA, pAI0CAT2 ; L, 0.05 mM calcium; H, 0.35 mM calcium. 
the 1 02-bp fragment for CAT activation in fibroblasts and the breast 
epithelial cell line (Fig 7) . This fragment showed activity in the 
TM6 cell line and in primary fibroblasts. It also showed low levels of 
CAT activity in NIH 3T3 cell s. Thus, the removal of 147 bp from 
the 3' end of the 249-bp fragment resulted in a loss of cell-type 
specificity. 
DISCUSSION 
We have identified a 249-bp fragment that is able to acti vate CAT 
constructs driven by both heterologous and homologous promoters. 
Furthermore, this activation is potentiated by increased calcium 
levels and is epidermal keratinocyte specific. The 249-bp fragment 
lies within a 4.4-kb 3' flanking region of HK1, which had been 
previously identified as containing a calcium-inducible epidermal 
specific transcriptional enhancer [25] . This element is 2.2 kb down-
stream of the HKl polyadenylation site and 7.9 kb from the TAT A 
box ofHK1. One copy of the 249-bp fragment exhibits little induc-
tion in CAT activity in response to increased levels of calcium, 
whereas multiple copies of the fragment produce a significant in-
crease in CAT activity. In contrast to the 1.1-kb and 426-bp frag-
ments, the activation of CAT by the 249-bp fragment was not 
dependent on position or orientation. Thus the 249-bp fragment 
has all the hallmarks of an enhancer that is capable of eliciting a 
keratinocyte-specific response to increased calcium levels. The 249-
bp fragment can be deleted to 102 bp and still reta in activity but 
with a loss of cell-type specificity. 
It was generally observed that both absolute activity and calcium 
induction were reduced in the 1.1-kb deletants, commensurate with , 
the size of the deletion. In fact, multimerization of the 249-bp 
fragment is required to achieve levels of induction comparable to 
that of the parent fragment (Table I, compare p249> with p 1.1). The 
gain of activity with multimerization of enhancer elements has been 
observed in other systems, notably the SV 40 virus en hancer [36,37] 
where multiple copies of the enhancer reconstituted the activity of 
the single copy wild- type element. The reduction in activity seen in 
the sub-fragments may suggest the requirement for other elements, 
distinct from the calcium-inducible enhancer, to interact with this 
cis-element in order to achieve the maximal response. These e1e- I 
ments, if they exist, have no intrinsic erulal1cer activity of them-
selves, as the 797 -bp fragme nt was unable to activate pA 1 OCAT 2 in 
transfected keratinocytes (data not shown and Fig 3B ). Neverthe-
less, synergism between elements located 3' of the 1.1-kb fragment 
and the calcium-inducibl e enhancer w ithin the 249-bp fragment 
has been observed [25]. Alternatively, the element identified in this 
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Figure 7. Sequences respomible for cel l-typespecifici.ty lie 5' to tbe. 102-bp fr."gment (+7820 to +7922). Detai ls of the constructs are given in Table I. 
Constructs were transfected 111 A) pnmaty munne kerat1l10cytes. B) pnmary mur1l1e dermal fibroblasts. C) NIH 3T3 fibrob lasts . and D) TM6 breast epithelial 
cells. Representative assay from two independent experiments. pSV2 • pSV2CAT; pA. pAI0CAT2 ; L. 0.05 mM calcium; H . 0.35 Il1M calcium. 
study may be sensitive to positional effects and to the composition of 
the local DNA environment. 
All the active fragments reported here showed some activity in 
low calcium (0 .05 mM). Some basal activity from this element may 
be expected given that the 10.8-kb HKl transgene is expressed in 
some basal cells with mitotic potential [24]. Recent eVidence from 
this laboratory suggests that the region specify ing suppression of 
HKl expression in the basal cells lies some 6 kb upstream from the 
promoter (JAR and DRR. unpublished observations). In this con-
text, the 3' regulatory region identified in this study would be 
predicted to be involved with the enhancement of HKl gene ex-
pression once the keratinocyte leaves the basal layer and makes the 
commitment to differentiate, rather than specifying the suppression 
of transcription in a cell with proliferative potential. 
This study has shown that the calcium-inducible enhancer within 
the 249-bp fragment is ab le to upregulate its homologous promoter 
(Fig .5). The 1.2-kb regIOn 5' to the ATG of HKl appears to be 
deVOid of enhancer elements as it is unable to initiate transcription 
by Itself, suggestl11g that the 3' regulatory element identified in this 
study is functionally important for HKl gene transcription. It is of 
I11terest to note here that a human K14 construct containing 1 kb of 
5' sequence information was unabl e to initiate transcription without 
the presence of a distal element [38]. The distal regulatory element 
has not been identified but the proximal element contains an AP-2 
site near the TATA box of human K14 [38,39]. A similar site exists 
in the promoter region of HKl and the resu lts from this study 
would predict that transacting factors binding to the calcium-indu-
cible enhancer interact with the AP-2 promoter complex to initiate 
transcription. 
An important observation from this study is that tissue specificity 
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appears to be defined by sequences 3' to the 102-bp fragment be-
tween + 7921 and + 8069 (Fig 7). Although it has been recently 
reported that sequences specifying cell-type specificity lie 3' to the 
1.1-kb fragment between +9288 and +9495 [25]. our data un-
equivocally show that the 1.1-kb fragment and the 249-bp frag-
ment derived from it exhibit a high degree ofkeratinocyte specific-
ity independent of the promoter used (Fig 6) . At this stage it is not 
clear why the data from the two studies are at variance. Recent 
footprint analysis of the 249-bp fragment has revealed two adjacent 
protein-binding regions at positions + 7895 to + 7921 and + 7924 
to + 7948 (Bo Lu and DRR. unpublished observations). We specu-
late that the distal footprint is responsible for determining keratino-
cyte specificity as it lies 3' to the 102-br fragment. The proximal 
footprint encompasses an AP-l site [40 at position + 7903 and is 
encoded by the 102-bp fragment. This site is implicated as the 
element that mediates the calcium response. as a fragment where 
this region has been disrupted failed to elicit activity from the re-
porter construct. A second potential AP-l site at position + 8048 
was identified by sequence homology comparison in the earlier 
study [25] but is apparently not functional in keratinocytes. This site 
was not protected in the footprint analysis of the 249-bp fragment 
(Bo Lu. unpublished observations) and fragments containing this 
site and not the more 5' AP-l site. were unable to activate 
pAI0CAT2 (Fig 3B and data not shown). 
AP-l is the collective term for the transacting factors Fos and Jun. 
and related proteins. The AP-l complex consists of either Jun-Jun 
or J un-Fos dimers. which recognize and bind to the AP-l consensus 
sequence. TGAGTCA [41]. AP-l sites have been identified in the 
genes encoding keratin 8 (K8) and its partner. K18 [42.43]. Interest-
ingly. an AP-l site identified in the 3' flanking region of mouse K8 
lies 7815 bp from the start of transcription [42]. which compares to 
the AP: 1 site at position + 7903 found within the 3' flanking region 
of the HKl gene. It is not known whether the AP-1 sites reported 
for the mouse K8 gene are functional; however. human K18 has 
been shown to be regulated by c-Jun and c-Fos through an AP-1 site 
within the first intron [43]. Functional AP-l sites have also been 
identified in the promoter regions of human papillomaviruses 
(HPV) types 16 and 18 [44 - 47]. As these viruses are tissue specific 
and replicate in differentiating keratinocytes. they may potentially 
share regulatory features with the differentiation-specific keratins. 
Although it has been reported that a keratinocyte-specific AP-l 
factor may be involved in directing cell-type specific expression 
from the HPV18 promoter [45]. a more recent study suggests that a 
keratinocyte-specific transcription factor (KRF-l) interacts with 
AP-l to direct HPV-18 gene expression in keratinocyte cell lines 
[46]. Footprint analysis of the HPV18 promoter has revealed that 
the KRF-l cis-element lies 3' to the AP-1 site [46]. similar to the 
organization found for the protected regions of the 249-bp frag-
ment. However. a search for KRF-l binding sequences within the 
249-bp fragment showed no significant homology. 
AP-l is well suited to mediate the calcium response because its 
activity can be modulated by the relative concentration of the 
various members of the Fos and Jun transacting factor families [48] . 
Recent studies on the expression of AP-l transacting factors in skin 
have shown that JunE is the predominant Jun component and its 
expression is limited to the suprabasallayers of the epidermis [49]. In 
vitro studies confirm that human epidermal keratinocytes express 
mainly JunE. with someJunD and little to no c-Jun [47] . c-fos. on 
the other hand. has been shown to be transiently in.duced in differ-
entiated epidermal keratinocytes in vitro [50] and its expression has 
been localized to the upper granular layers of the epidermis [51]. 
where calcium levels have been shown to be the highest. Moreover. 
calcium has been shown to induce transcription of both fos and jul). 
([52] and references therein). suggesting the possibility that the 
levels of these transacting factors may be regulated by the level of 
intracellular calcium within the differentiating keratinocyte. These 
observations lead us to propose that calcium induction of HKl may 
be mediated through the upregulation of AP-l transacting factors 
and their subsequent interactions with specific sequences located 
within the 249-bp epidermal-specific enhancer. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
This study delineates an epidermal-specific enhancer that can be 
modulated by differing levels of calcium and is capable of activating 
both homologous and heterologous promoters in the absence of 
other enhancer elements. The sequences that specify cell- type spec-
ificity are distinct from those that mediate the calcium response. 
The ubiquitous transacting factor AP-l appears to be responsible for 
mediating the calcium response . Finally . we believe that we have 
identified the cis-element through which calcium exerts its control 
on the regulation of the HKl gene. 
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